Improve walking rhythm and balance
- Trial ID
- NCT06174948
- Official Title
- The Use of the CUE1/CUE1+ Device in People With Idiopathic Parkinson's Disease and Related Disorders: A Feasibility Study
- Goal
- Improve walking rhythm and balance
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Queen Mary University of London
- Study Type
- INTERVENTIONAL
- Enrollment
- 70 participants
- Conditions
- Parkinson's Disease and Parkinsonism, Progressive Supranuclear Palsy, Different Types of Tremor Including Essential Tremor, Dystonia, Multiple System Atrophy, Corticobasal Degeneration, Vascular Parkinsonism, Orthostatic Tremor
- Interventions
- CUE1 non-invasive device, CUE1+ device active vs sham CUE1+ device
Plain-Language Summary
The goal is to test whether a wearable tactile cueing device can be used safely and practically, and whether its vibration cues might help the timing of movement, gait and balance in people with Parkinson's and related movement disorders. Participants wear the non-invasive CUE1 or CUE1+ device, usually on the sternum, which delivers short vibrotactile pulses to provide an external rhythm for steps and posture; the trial compares active versus sham CUE1+ and the device is non-drug so it is used alongside stable Parkinson's medications rather than replacing them. The study is looking for adults 18 and older with idiopathic Parkinson's or related conditions such as PSP, MSA, CBD, vascular parkinsonism, atypical dystonias, various tremor disorders and orthostatic tremor, who can give informed consent and have been on a stable dose of Parkinson's medicines for the past three months. People with cognitive impairment or dementia, severe hearing or visual problems, implanted metal or electronic devices, skin issues where the device would sit, or hypersensitivity to vibrotactile stimulation are excluded.
Locations
- Queen Mary University of London, London, United Kingdom
Frequently Asked Questions
- What is this trial testing?
- This trial is studying CUE1 non-invasive device. The goal is to test whether a wearable tactile cueing device can be used safely and practically, and whether its vibration cues might help the timing of movement, gait and balance in people with Parkinson's and related movement disorders. Participants wear the non-invasive CUE1 or CUE1+ device, usually on the sternum, which delivers short vibrotactile pulses to provide an external rhythm for steps and posture; the trial compares active versus sham CUE1+ and the device is non-drug so it is used alongside stable Parkinson's medications rather than replacing them. The study is looking for adults 18 and older with idiopathic Parkinson's or related conditions such as PSP, MSA, CBD, vascular parkinsonism, atypical dystonias, various tremor disorders and orthostatic tremor, who can give informed consent and have been on a stable dose of Parkinson's medicines for the past three months. People with cognitive impairment or dementia, severe hearing or visual problems, implanted metal or electronic devices, skin issues where the device would sit, or hypersensitivity to vibrotactile stimulation are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year.